While high total IgE can be an incidental finding or a non-specific response to infection, the prompt and dramatic resolution of symptoms following anti-IgE therapy strongly suggests that the IgE/mast cell pathway was a critical and targetable effector mechanism driving the severity of the refractory urticaria in these cases, irrespective of the initial trigger (infection or potential sensitization). This evidence concerns the gene IGHE and infection.